Building the future of bioprocess at Ark, so that more breakthrough innovation can break through from the lab to the world faster. Ark is accelerating bioprocess with game changing simulation and computational modeling software and an intelligent bioreactor system. The status quo in biomanufacturing - outdated technology, long and costly development timelines - is badly in need of reinvention. Our platform holistically addresses bioprocess, ultimately helping the science that saves lives and reverses climate change get to market faster.At Ark, I lead operations and finance, and get to work with some of the most talented engineers and scientists. I'm motivated by hard-to-solve problems and hard-to-build technology. Prior to Ark, I worked on the growth equity investment team at AXA Venture Partners, where I had the opportunity to work with some of the most innovative companies, reinventing industries like logistics (Tive) and corporate learning (Lessonly). I started my career off in consulting at Parthenon-EY.You can reach me at: ada@ark-biotech.com